Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000514

Drug Information
NameBenzonatate
SynonymsPolyethyleneglycol-p-n-butylaminobenzoate methyl ester; Benzoic acid, 4-(butylamino)-, 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester (9CI); Tessalin; Prestwick3_000012; LS-36322; Benzonatate (USP/INN); DB00868; C30H53NO11; NCGC00016362-01; SMR001233469; Prestwick0_000012; Benzononatine; MLS002154171; UNII-5P4DHS6ENR; Tesalon; nonaethyleneglycol monomethyl ether p-n-butylaminobenzoate; Benzonatatum [INN-Latin]; Benzononantin; 104-31-4; MolPort-005-941-702; Benzoic acid, 4-(butylamino)-, 2,5,8,11,14,17,20,23,26-nonaoxaoctacos-28-yl ester; 3,6,9,12,15,18,21,24,27-Nonaoxaoctacos-1-yl 4-(butylamino)benzoate; AC1Q68HL; p-butylaminobenzoic acid omega-O-methylnonaethyleneglycol ester; 4-(butylamino)benzoic acid 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester; Prestwick2_000012; 2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl 4-(butylamino)benzoate; 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoate; Benzonatate [USAN:INN:BAN]; SPBio_001964; Exangit; Tessalon; 3,6,9,12,15,18,21,24,27-nonaoxaoctacosyl 4-butylaminobenzoate; p-(n)-Butylaminobenzoesaeure-(nonaaethylenglykol-monomethylaether)-ester [German]; Ventussin; EINECS 203-194-7; Tessalon-ciba; Benzoic acid, 4-(butylamino)-, 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester; AR-1H9260; 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl p-(butylamino)benzoate; BSPBio_000043; Tessalon Perles; HMS1568C05; Benzonatato [INN-Spanish]; CHEBI:3032; BPBio1_000049; Benzonatate; AC1L1PCL; KM65; CAS-104-31-4; Benzonatatum; Tessalon perles (TN); Ventussin-loz; Benzoic acid, p-(butylamino)-, 2-(2-(2-(2-(2-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl ester; p-(n)-Butylaminobenzoesaeure-(nonaaethylenglykol-monomethylaether)-ester; D00242; CID7699; NCGC00016362-02; AB00513795; 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate; Benzonatato; Prestwick1_000012
Trade NameTessalon Perles; Tessalon Capsules
IndicationCough
[ICD9: 786.2   ICD10: R05]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-2
4-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-
33-2/h5-8,31H,3-4,9-27H2,1-2H3
InChIKeyMAFMQEKGGFWBAB-UHFFFAOYSA-N
Canonical SMILESCCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC    
Therapeutic ClassAntitussives
CAS NumberCAS 104-31-4
FormulaC30H53NO11
PubChem Compound IDCID 7699.
PubChem Substance IDSID 150787.
SuperDrug ATC IDR05DB01
SuperDrug CAS ID000104314;
TargetSodium channel protein type 5 subunit alphaBlocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040587 To Reference
Ref 2How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543